Hemodialysis Market Poised To Register Healthy Expansion For Upcoming Years By Growing PLayers Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International, Inc., Cantel Medical Corp., DaVita, Inc., Diaverum & Others

The global hemodialysis market is driven by increase in incidence of hypertension and diabetes. Moreover, rise in number of end stage renal disorder (ESRD) patients and shortage in availability of kidneys for transplants are the key factors that augment the growth of the market. However, numerous product recalls and risks and complications associated with dialysis are some of the factors that hinder the market growth. On the contrary, the presence of untapped markets in the emerging nations is expected to provide new opportunities for the key players.

The global hemodialysis market size was valued at $71,501 million in 2017 and is expected to reach $99,747 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4660

The function of kidneys is to remove waste products and excess fluid from the blood. If the kidneys do not function normally, this process is implemented by hemodialysis. Waste products, such as urea and creatinine, are removed from the blood with the help of artificial and natural semipermeable membranes.

The major driving factors for the growth of the global hemodialysis market are increase in the number of end-stage renal disease (ESRD) patients, rise in incidence of diabetes and hypertension, and increase in funding for improved dialysis products and services. Moreover, owing to lack of matching donors, dialysis is preferred over kidney transplant, which is expected to further fuel market growth. However, risks and complications associated with dialysis and product recall are expected to hamper market growth.

By product and service, the service segment accounted for approximately two-thirds share of the global hemodialysis market in 2017. Furthermore, the nocturnal segment is anticipated to grow at the highest rate of 4.9% during the forecast period.

Key Findings of the Hemodialysis Market :

- North America occupied less than two-thirds share of the global hemodialysis market in the year 2017.
- The consumable segment is anticipated to grow with the highest CAGR throughout the forecast period.
- Europe is anticipated to nearly occupy a one-third market share of the global hemodialysis medicine market by 2025.
- The Asia-Pacific region is anticipated to grow at the highest rate during the forecast period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to presence of a large population base along with a well-established healthcare infrastructure and technological advancements in patient care. However, Asia-Pacific is expected to grow at the highest CAGR of 6.6% from 2018 to 2025, owing to rise in government initiatives to establish new dialysis centers, increase in awareness related to dialysis products in the market, and increase in the number of independent dialysis centers.

The report provides an extensive competitive analysis and profiles of the key market players, such as

- Asahi Kasei Corporation,
- B. Braun Melsungen AG,
- Baxter International, Inc.,
- Cantel Medical Corp.,
- DaVita, Inc.,
- Diaverum,
- Fresenius Medical Care AG & Co. KGaA,
- Nikkiso Co., Ltd.,
- Nipro Corporation, and
- NxStage Medical, Inc.

The other players in the value chain (not included in the report) include Gambro, Satellite Healthcare, Inc., and MEDIVATORS, Inc.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4660

Table Of Content

Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Clinical trials
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase in funding for improved dialysis products and services
3.4.1.2. Increase in the number of ESRD patients
3.4.1.3. Rise in incidence of diabetes and hypertension
3.4.1.4. Shortage of kidneys for transplantation
3.4.2. Restraints
3.4.2.1. Risks and complications associated with dialysis
3.4.2.2. Product recall
3.4.3. Opportunities
3.4.3.1. Technological advancements leading to better adoption
3.4.3.2. Growth opportunities in emerging economies
3.4.4. Impact Analyses
3.5. Patent analysis (2013-2018)
3.5.1. Patent analysis, by year

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/hemodialysis-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.